Unibest
← Back to patent-cliff list

CAS 2222653-74-7

4-(6-fluoropyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridine-3-carbonitrile

Codes: SELP-018

Application context (from source-drug indications)

Solid tumourSelpercatinibMedullary thyroid cancerSelpercatinibNon-small cell lung cancerSelpercatinibThyroid cancerSelpercatinib

Source drugs (routes using this intermediate)

DrugTierExpiry
SelpercatinibTier C — Watch / trade2032

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

SelpercatinibOptimised routesteps: 2total yield: 45.3 g (Selpercatinib)

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.